Full side-by-side comparison — 2026
Data as of Aug 24, 2026 · Updated automatically
| Metric | DHR | TMO |
|---|---|---|
| Current Price | 215.42 | 626.56 |
| Previous Close | 215.11 | 628.74 |
| Metric | DHR | TMO |
|---|---|---|
| Trailing P/E | 37.35 | 33.90 |
| Forward P/E | 22.53 | 22.87 |
| Price / Book | 2.80 | 4.42 |
| Price / Sales | 5.87 | 5.02 |
| EV / EBITDA | 20.41 | 23.11 |
| Metric | DHR | TMO |
|---|---|---|
| Dividend Yield | 0.0066% | 0.0029% |
| Dividend Rate (Annual) | 1.44 | 1.80 |
| 5-Year Avg Yield | 0.38% | 0.23% |
| Payout Ratio | 0.2408% | 0.0949% |
| Metric | DHR | TMO |
|---|---|---|
| Beta (Volatility) | 0.80 | 0.85 |
| Debt / Equity | 52.97 | 80.58 |
| Quick Ratio | 1.15 | 1.01 |
| Current Ratio | 1.65 | 1.55 |
| Metric | DHR | TMO |
|---|---|---|
| Revenue Growth | 0.0550% | 0.1050% |
| Earnings Growth | 0.5970% | 0.0940% |
| Return on Equity | 0.0761% | 0.1352% |
| Revenue / Share | 35.47 | 123.89 |
| Trailing EPS | 5.61 | 18.56 |
| Forward EPS | 9.30 | 27.51 |
| Metric | DHR | TMO |
|---|---|---|
| Analyst Mean Target | 227.96 | 631.42 |
| Analyst High Target | 310.00 | 750.00 |
| Analyst Low Target | 195.00 | 520.00 |
Danaher Corporation (DHR) leads on 10 of 19 comparable metrics.
Danaher Corporation is the stronger pick for income investors, while Thermo Fisher Scientific Inc. may appeal to growth investors.
This comparison is based on publicly available financial data and is for informational purposes only. It is not investment advice. Past performance does not guarantee future results.
Based on analyst mean price targets. Estimates are not guaranteed and may not reflect future performance.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and …
View DHR details →Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, …
View TMO details →Add both to AllInvestView and compare their real-time performance, dividends, and gain/loss side by side.
Start Free Portfolio